What You Should Know:
– Viz.ai, an AI-powered disease detection and intelligent care coordination has signed an exclusive licensing agreement with University of California, San Francisco (UCSF) to commercialize three AI algorithms for the automated detection of cardiovascular diseases.
– Developed at UCSF by leading researchers, these AI algorithms to detect cardiac amyloidosis, pulmonary hypertension, and supraventricular tachycardia are based on analysis of electrocardiograms (ECGs), the most widely used diagnostic test for characterization of cardiac structure and electrical activity of the heart.
– Following regulatory clearance, these three new algorithms will be a part of Viz.ai’s expanding offering, which includes ECG-based AI algorithms, ECG viewer, AI-interpretation of echos and echo viewer, enabling cardiac care teams to detect disease earlier and coordinate care in real time.
